Correlates of being outside the 90-90-90 cascade among adults aged 15-64 years in Zimbabwe: Results from the 2015-2016 Zimbabwe Population-based HIV.

Slides:



Advertisements
Similar presentations
South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 Presenter: Prof LC Simbayi Executive Director, HAST Programme, Human Sciences.
Advertisements

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
1,2 BABALOLA OS, 1,2 BELLO B, 1 NDLOVU N 1 UNIVERSITY OF THE WITWATERSRAND, & 2 CENTRE FOR STATISTICAL ANALYSIS & RESEARCH (CESAR), JOHANNESBURG, SOUTH.
Trends in HIV prevalence and HIV incidence in South Africa Thomas M. Rehle, MD, PhD Human Sciences Research Council (HSRC) Cape Town, South Africa AIDS.
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Performance Monitoring of Tuberculosis Infection Control in Zimbabwe: introduction of a novel color-coded evaluation tool Tendayi Jubenkanda On behalf.
High HIV, HBV and HCV Prevalence among People Who Inject Drugs: Results from the First Integrated Bio-behavioral Survey of PWID in Mozambique Authors:
Beliefs about Male Circumcision among Men from a Traditionally Non- Circumcising Community in Rural Western Kenya, Adega, A, Burmen, B, Mutai,
Correlates of HIV testing among youth in three high prevalence Caribbean Countries Beverly E. Andrews, Doctoral Candidate University.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
1 High levels of risk behavior among people living with HIV initiating and waiting to start antiretroviral therapy in Cape Town South Africa TP Eisele,
Findings from the 2016 Zambia Population-based HIV Impact Assessment (ZAMPHIA): HIV prevalence, incidence and progress towards the goals Danielle.
Are we there yet? Spatial-temporal trend of mother to child HIV transmission in western Kenya, Anthony Waruru, Thomas Achia, Hellen Muttai, Lucy.
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Children Living with HIV in Malawi: Results from the Malawi Population-based HIV Impact Assessment (2016) Jonnalagadda S1, Bello G2, Saito S3, Burnett.
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
I have no conflicts of interest to declare
Young People (15-24 year) Last updated: February 2017.
KwaZulu-Natal, South Africa
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
2Ministry of Health and Child Care, AIDS & TB Unit, Harare, Zimbabwe
Introduction and Methodology
No conflicts of interest to declare.
9th IAS Conference on HIV Science
Participants 18year old+
HIV treatment cascade analysis for people who inject drugs in Ukraine: identifying the correlates of HIV care outcomes Kostyantyn Dumchev1, Olga Varetska2,
Zimbabwe’s shift towards treat all: national country context
Conclusions & Implications
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Ambassador Deborah L. Birx, MD
Conclusions Background Results Acknowledgements: Methods
Pakistan Last updated: July 2015.
Believed discrimination occurred because of their:
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana ¹Obiri-Yeboah Dorcas, School of Medical Sciences,
Prevention of mother to child transmission and early infant diagnosis in Malawi: Accomplishments of a mature Option B+ program in a resource-limited setting.
Centre for International Health, University of Bergen, Norway
Shoo T, Kamala B, Rosecrans K, Miller K, Al-Alawy H, Rwezahura P
Being physically abused Adjusted Odds Ratio (95% CI)
SEXUAL RISK BEHAVIOR OF PLWHA IN THE WA MUNICIPALITY
Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,
Hepatitis B Vaccination Assessment Adults Aged Years National Health Interview Survey, 2000 Gary L. Euler, DrPH1, Hussain Yusuf, MBBS2, Shannon.
Management and Development for Health (MDH)
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Young People (15-24 year) Last updated: December 2018.
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
HIV Testing in the U. S. Julie Saber Galen College of Nursing
Stakeholder engagement and research utilization: Insights from Namibia
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Knowledge of HIV Status in Kenya
HIV Recency Testing in Rwanda
Presentation transcript:

Correlates of being outside the 90-90-90 cascade among adults aged 15-64 years in Zimbabwe: Results from the 2015-2016 Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) Avi J Hakim1, Elizabeth Radin2, Leala Ruangtragool1, Amy Herman-Roloff1, Nahima Ahmed2, Godfrey Musuka2, Hazel Dube2, Mutsa Mhangara3, Lovemore Gwanzura4, Shungu Munyati4, Elizabeth Gonese1, Amaka Nwankwo-Igomu1, Hetal Patel1, Katrina Sleeman1, Steven Kinchen1, Jessica Justman2, Beth A Tippett-Barr1 for the ZIMPHIA Survey Team 1 U. S. Centers for Disease Control and Prevention; 2 ICAP at Columbia University; 3 Ministry of Health and Child Care, Zimbabwe; 4 Biomedical Research and Training Institute, Zimbabwe 25 July 2017 9th IAS Conference on HIV Science Center for Global Health Division of Global HIV & TB

Zimbabwe Population: 14.5 million 2015 UNAIDS HIV prevalence: 14.7% among 15-49 year olds HIV treatment is free for Zimbabweans HIV treatment eligibility 2013: CD4<500 cells/µL December 2016: Treat all

Objective ZIMPHIA conducted October 2015-August 2016 to assess national HIV incidence and the 90-90-90 cascade at a subnational level To describe the 90-90-90 cascade among 15-64 year olds in Zimbabwe and correlates of being outside each level of the cascade (or, being in the 10-10-10 cascade)

METHODS

Sampling Method Two-stage cluster-based nationally representative household survey using population-proportional to size within strata Stage 1: 500 enumeration areas across 10 strata Stage 2: 15,009 households

Data Collection Household and individual interview HIV-related testing Rapid testing with: Determine, First Response (confirmation), Stat-Pak (tie breaker) Results returned same day Laboratory: Geenius for quality assurance Viral load with Roche Cobas AmpliPrep/Cobas TaqMan platform Results returned to health facility in participant’s district after ~10 weeks

Analytic Methods Data weighted for survey design and non-response Multivariate models: p<0.10 in bivariate analysis p<0.05 in multivariate analysis Variables considered: age, gender, urban/rural, province, education, marital status, condom use last sex 12 months, number sex partners last 12 months, sold sex last 12 months

Outcome Measures First 10: HIV-infected and unaware of HIV status Second 10: Aware of HIV infection but not on treatment Third 10: On treatment but not virally suppressed All outcomes measures save for viral suppression were self-reported

Results

Response Rate Among Individuals Aged 15-64 Years, ZIMPHIA 2015-2016 15,009 HH Selected 13,828 HH Occupied 83.9% Interviewed Males Rostered 11,923 Males Eligible 11,098 Males Interviewed 9,271 (82.3%) Males Tested for HIV 8,395 (90.2%) Females Rostered 14,534 Females Eligible 14,033 Females Interviewed 13,219 (93.9%) Females Tested for HIV 12,182 (91.8%)

Response Rate Among Individuals Aged 15-64 Years, ZIMPHIA 2015-2016 15,009 HH Selected 13,828 HH Occupied 83.9% Interviewed Males Rostered 11,923 Males Eligible 11,098 Males Interviewed 9,271 (82.3%) Males Tested for HIV 8,395 (90.2%) Females Rostered 14,534 Females Eligible 14,033 Females Interviewed 13,219 (93.9%) Females Tested for HIV 12,182 (91.8%)

Response Rate Among Individuals Aged 15-64 Years, ZIMPHIA 2015-2016 15,009 HH Selected 13,828 HH Occupied 83.9% Interviewed Males Rostered 11,923 Males Eligible 11,098 Males Interviewed 82.3% Males Tested for HIV 90.2% Females Rostered 14,534 Females Eligible 14,033 Females Interviewed 93.9% Females Tested for HIV 91.8%

ZIMPHIA National HIV Prevalence: 14.1%

Zimbabwe Testing and Treatment Cascade 27.1% 13.2% 13.5% 72.9% 86.8% 86.5% 63.3% 59.6%

1. Correlates of being unaware of HIV Age aOR (95% CI) 15-24 4.8 (2.9-7.8) 25-34 1.8 (1.2-2.7) 35-44 0.9 (0.6-1.4) 45-54 0.9 (0.6-1.3) 55-64 ref 15

1. Correlates of being unaware of HIV Gender aOR (95% CI) Female ref Male 1.9 (1.5-2.3) 16

1. Correlates of being unaware of HIV Marital status aOR (95% CI) Never married 1.7 (1.1-2.6) Married or living together 0.9 (0.6-1.3) Divorced or separated 1.5 (1.0-2.3) Widowed ref 17

1. Correlates of being unaware of HIV Condom use at last sex in last 12 months aOR (95% CI) Used 0.7 (0.4-1.2) Did not use 3.5 (2.3-5.5) Did not have sex ref Not significant in multivariate analysis: Education Number sex partners last 12 months 18

2. Correlates of being aware but not on treatment Age aOR (95% CI) 15-24 4.6 (2.0-10.9) 25-34 4.2 (2.2-7.8) 35-44 2.9 (1.5-5.5) 45-54 1.2 (0.6-2.5) 55-64 ref

2. Correlates of being aware but not on treatment Condom use last sex in last 12 months aOR (95% CI) Used condom 1.3 (0.8-2.3) Did not use condom 3.1 (1.9-5.1) Did not have sex ref

2. Correlates of being aware but not on treatment Number sex partners last 12 months aOR (95% CI) 1 ref 2+ 1.8 (1.1-2.8) Not significant in multivariate analysis: Education Marital status

3. Correlates of being on treatment but not virally suppressed Age aOR (95% CI) 15-24 3.0 (1.2-7.6) 25-34 3.7 (2.0-6.8) 35-44 3.3 (1.8-6.2) 45-54 1.4 (0.7-2.7) 55+ Ref

3. Correlates of being on treatment but not virally suppressed Gender aOR (95% CI) Female Ref Male 1.6 (1.2-2.2) Not significant in multivariate analysis: Condom use at last sex in last 12 months

Number of people aged 15-64 years not reached 311,000 people not aware of their HIV status 422,000 people not on treatment 465,000 people not virally suppressed

Limitations and next steps Relies on self-reported awareness and treatment status Proportion not virally suppressed includes people who may have just started treatment and would not be suppressed yet Next steps: Test specimens for presence of antiretroviral medications Explore interactions between key variables Examine reasons for being in the 10-10-10 cascade Estimate population attributable risks

Conclusions Males, people <45 years of age, the never married or divorced/separated, those not using condoms at last sex in 12 months, and those with 2+ sex partners in last 12 months were most likely not to be reaching UNAIDS goals Factors should be carefully considered when developing policies and services Results provide a valuable baseline for impact of treat all

Acknowledgements and Thanks Participants Field workers Zimbabwe Ministry of Health and Child Care U.S. Centers for Disease Control and Prevention ICAP at Columbia University Zimbabwe National AIDS Council Zimbabwe National Statistics Agency Biomedical Research & Training Institute in Zimbabwe Lancet Laboratories Statistical Center for HIV/AIDS Research and Prevention Westat This survey was supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through CDC under the terms of cooperative agreement #U2GGH001226. The contents of this presentation do not necessarily reflect the views of the United States Government. 27

Thank you